anti brca2 antibody (Cell Signaling Technology Inc)
Structured Review
Anti Brca2 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+brca2/pmc12969137-6-0-3
Average 86 stars, based on 1 article reviews
Images
Related Articles
other:Article Title: Pimitespib, an HSP90 Inhibitor, Enhances the Efficacy of PARP Inhibitors in PARP Inhibitor‐Insensitive Breast Cancer Cells Article Snippet: Article Title: Pimitespib, an HSP90 Inhibitor, Enhances the Efficacy of PARP Inhibitors in PARP Inhibitor-Insensitive Breast Cancer Cells. Article Snippet: Expressing:Article Title: Tumor Treating Fields (TTFields), and their concomitant application with FOLFOX, are effective for the treatment of gastric cancer cells Article Snippet: Cells were acquired using flow cytometry and γH2AX positive cells analyzed using the FlowJo software ( for gating strategy). .. For determination of protein expression, cell extracts were prepared and subjected to western blot analysis (40 μg protein) as previously described ( , ), using the primary antibodies: anti-p21 (Santa Cruz, SC-6246, 1:500), anti-p27 (Santa Cruz, SC-56338, 1:500), anti-FANCD2 (Cell Signaling, 16323, 1:1000), anti-FANCJ (Cell Signaling, 4578, 1:1000), Western Blot:Article Title: Tumor Treating Fields (TTFields), and their concomitant application with FOLFOX, are effective for the treatment of gastric cancer cells Article Snippet: Cells were acquired using flow cytometry and γH2AX positive cells analyzed using the FlowJo software ( for gating strategy). .. For determination of protein expression, cell extracts were prepared and subjected to western blot analysis (40 μg protein) as previously described ( , ), using the primary antibodies: anti-p21 (Santa Cruz, SC-6246, 1:500), anti-p27 (Santa Cruz, SC-56338, 1:500), anti-FANCD2 (Cell Signaling, 16323, 1:1000), anti-FANCJ (Cell Signaling, 4578, 1:1000), Incubation:Article Title: Targeting branched N -glycans and fucosylation sensitizes ovarian tumors to immune checkpoint blockade Article Snippet: Proteins were separated by SDS-PAGE gel and transferred to a PVDF membrane (Millipore, IPVH00010). .. The membranes were blocked with 5% non-fat milk and incubated with primary antibodies overnight at 4 °C with gentle agitation using the following antibodies and dilutions: anti-β-actin (1:1000; Cell Signaling, Cat#: 4970, RRID:AB_2223172), Article Title: Targeting branched N-glycans and fucosylation sensitizes ovarian tumors to immune checkpoint blockade. Article Snippet: Proteins were separated by SDS-PAGE gel and transferred to a PVDF membrane (Millipore, IPVH00010). .. The membranes were blocked with 5% non-fat milk and incubated with primary antibodies overnight at 4 °C with gentle agitation using the following antibodies and dilutions: anti-β-actin (1:1000; Cell Signaling, Cat#: 4970, RRID:AB_2223172), Gentle:Article Title: Targeting branched N -glycans and fucosylation sensitizes ovarian tumors to immune checkpoint blockade Article Snippet: Proteins were separated by SDS-PAGE gel and transferred to a PVDF membrane (Millipore, IPVH00010). .. The membranes were blocked with 5% non-fat milk and incubated with primary antibodies overnight at 4 °C with gentle agitation using the following antibodies and dilutions: anti-β-actin (1:1000; Cell Signaling, Cat#: 4970, RRID:AB_2223172), Article Title: Targeting branched N-glycans and fucosylation sensitizes ovarian tumors to immune checkpoint blockade. Article Snippet: Proteins were separated by SDS-PAGE gel and transferred to a PVDF membrane (Millipore, IPVH00010). .. The membranes were blocked with 5% non-fat milk and incubated with primary antibodies overnight at 4 °C with gentle agitation using the following antibodies and dilutions: anti-β-actin (1:1000; Cell Signaling, Cat#: 4970, RRID:AB_2223172), |

